What Has Been the Progress and Growth of the Diverticulitis Disease Market in Recent Years?
The diverticulitis disease market has seen considerable growth due to a variety of factors.
• The market size for the diverticulitis disease has seen a swift expansion over the past few years. It is projected to rise from $1.85 billion in 2024 to $2.04 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%.
The growth previously observed can be linked to factors such as an aging population, dietary practices, obesity, and advancements in medical imaging technology.
How Does the Forecast Look for the Diverticulitis Disease Market?
The diverticulitis disease market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for diverticulitis disease is predicted to exhibit robust growth in the coming years. It's expected to increase to $2.92 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.4%.
The surge during the forecasted period can be credited to factors such as endoscopy and colonoscopy, a heightened sense of awareness, less invasive operation procedures, and individualized treatments. The major trends anticipated in this period incorporate preventive strategies, improved diagnosis tools, cooperative healthcare models, and alterations in healthcare policies.
What Are The Leading Drivers Of Growth In The Diverticulitis Disease Market?
The escalating trend of smoking is predicted to spur the development of the diverticulitis disease market. This increase in smoking habits stems from compelling advertising, its acceptance in society, stress, and the addictive characteristics of nicotine. The proliferation of e-cigarettes and vape devices, as well as social influences and peer pressure among the young, contribute to the skyrocketing rates of smoking. Smoking elevates the risk of developing diverticular disease by weakening the colon's blood flow, leading to graver complications; this fosters a greater need for diagnosis and treatment methods. For example, in July 2022, Statistics Canada reported a 5.8% increase in cigarette production compared to June 2021. Furthermore, the total cigarette sales recorded a 1.3% boost from May 2022, achieving 1.4 billion in June 2022. Consequently, the increasing smoking prevalence is playing a key role in diverticulitis disease market's expansion. A surge in diabetes incidence is projected to instigate further growth in the diverticulitis disease market. This rise can primarily be attributed to factors such as unhealthy diets laden with processed foods, sedentary lifestyles, escalating obesity rates, genetic factors, and an aging population. Diabetes exacerbates the risk of complications such as weakened blood vessels, making the colon more vulnerable to infections and inflammation, thereby increasing the need for various treatments and therapies. To illustrate, NHS England reported that as of June 2024, the figure for people identified as pre-diabetic rocketed to 3,615,330 in 2023, marking an upswing of 18% from 3,065,825 in 2022. Of note were the alarming numbers in the under 40 demographic, which saw almost a 25% increase, with cases ballooning from 173,166 in 2022 to 216,440 in 2023. Bearing this data in mind, one can assert that the escalating prevalence of diabetes is fuelling the growth of the diverticulitis disease market.
How Are The Segments Defined Within The Global Diverticulitis Disease Market?
The diverticulitis disease market covered in this report is segmented –
1) By Type: Uncomplicated, Complicated
2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test
3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids
4) By End-User: Specialty Centers, Hospitals, Research centers
Subsegments:
1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy
2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage
Pre-Book The Diverticulitis Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Diverticulitis Disease Market?
Leading companies in the diverticulitis disease market are focusing on producing creative drugs and obtaining necessary approvals to maintain their market position. Through drug invention, more effective treatments for diverticiculitis can be achieved, minimizing the possibilities of complications and enhancing patient results. For example, Seres' microbiota drug for recurrent gut infections was approved by the US-based federal organization, the United States Food and Drug Administration, in April 2023. The medicine aims to treat persistent gut infections and prevent the reappearance of Clostridioides difficile (C. diff.) infections in adults who are at least 18 years old. The authorization for Vowst was granted following a clinical trial involving 346 patients with recurrent CDI. Results showed that patients administered with Vowst had a significant decrease in the risk of infection recurrence compared to those given a placebo. The drug, administered orally, is comprised of microbiota with Firmicutes spores, which contribute to a healthy microbiome capable of resisting C. diff. colonization.
Who Are the Key Players In The Diverticulitis Disease Market?
Major companies operating in the diverticulitis disease market are:
• Pfizer Inc.
• Johnson and Johnson
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Company
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Endo Pharmaceuticals
• Aspen Pharmacare
• Zydus Lifesciences
• Lupin Limited
• Glenmark Pharmaceuticals
• Alkem Laboratories
• Torrent Pharmaceuticals Ltd.
What Is The Most Dominant Region In The Diverticulitis Disease Market?
North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
